MSD launches Sivextro, first new antibiotic launched in the UK for nearly 15 years, to treat MRSA-type skin infections
MSD (known as Merck & Co., Inc. in the US and Canada) has announced the availability in the UK of Sivextro® (tedizolid phosphate) for the treatment of acute bacterial skin and skin structure...